Related Experiment Video
Updated: Jun 21, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Management of HCV infection: current issues and future options
1Department of Medicine, Maulana Azad Medical College, New Delhi, India.
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
|July 24, 2009
Summary
Hepatitis C virus (HCV) treatment with PEG-IFN and ribavirin has limited success, especially for genotype 1 infections. New therapies are crucial for patients who do not achieve sustained virologic response (SVR).
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) causes chronic liver disease (CLD).
- Current standard treatment involves PEG-IFN and ribavirin, with variable sustained virologic response (SVR) rates.
- SVR rates are lower for HCV genotype 1 (42-56%) compared to genotypes 2 and 3 (76-82%).
Purpose of the Study:
- To highlight the limitations of current HCV therapies.
- To emphasize the need for improved treatment strategies for nonresponders and relapsers.
- To underscore the importance of developing new, effective, and safe antiviral agents for chronic hepatitis C.
Main Methods:
- Review of current treatment outcomes for chronic hepatitis C.
- Analysis of SVR rates based on HCV genotypes.
- Evaluation of factors influencing re-treatment decisions.
Main Results:
- Standard treatment fails to achieve SVR in a significant percentage of patients.
- HCV genotype 1 and advanced liver disease are associated with lower treatment efficacy.
- Current therapies have side effects impacting quality of life.
Conclusions:
- Existing treatments for chronic hepatitis C are insufficient for certain patient subgroups.
- Re-treatment decisions require careful consideration of clinical, virological, and histological factors.
- Development of novel therapeutic agents is essential for improving HCV management and patient outcomes.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...